Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Novel Compound Holds Promise in High-Risk CLLNovel Compound Holds Promise in High-Risk CLL
Link ID 38558
Title Novel Compound Holds Promise in High-Risk CLLNovel Compound Holds Promise in High-Risk CLL
Url http://www.medscape.com/viewarticle/755226?src=rsshttp://www.medscape.com/viewarticle/755226?src=rss
Description An experimental compound showed high efficacy and low toxicity in relapsed/refractory patients with chronic lymphocytic leukemia. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Dec 12, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Bevacizumab Ruling: FDA Delay Is Worst Possible Decision
  Dr. Kathy Miller takes aim at the FDA for skirting the Avastin decision and effectively putting breast cancer patients, researchers, and treating physicians in limbo for another 3 months. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


2. New Results for Exemestane Show Differences From Other Aromatase Inhibitors
  New results coming from 2 large trials with exemestane suggest that this aromatase inhibitor differs from the other 2 products on the market. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Treating Non-muscle-invasive Bladder Cancer: The AUA 2007 Update
  This update provides a succinct summary of the recently published revision of the AUA guideline on the management of non-muscle-invasive bladder cancer. Medscape Urology
Category:   Articles > Hematology-Oncology


4. Hodgkin Lymphoma: New Drug Breakthroughs
  Drs. Nancy Bartlett and Bruce Cheson discuss promising new drugs for patients with refractory Hodgkin lymphoma, including brentuximab vedotin (SGN-35). Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. Implications of a New Target in NSCLC Implications of a New Target in NSCLC
  The discovery of a new potential therapeutic target in non-small cell lung cancer prompts Dr. Howard (Jack) West to consider the clinical implications. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS